[go: up one dir, main page]

CN107085032A - A Peptide Derivatization Method and Its Application in MALDI‑TOF‑MS Detection of Drug Metabolites - Google Patents

A Peptide Derivatization Method and Its Application in MALDI‑TOF‑MS Detection of Drug Metabolites Download PDF

Info

Publication number
CN107085032A
CN107085032A CN201710083984.8A CN201710083984A CN107085032A CN 107085032 A CN107085032 A CN 107085032A CN 201710083984 A CN201710083984 A CN 201710083984A CN 107085032 A CN107085032 A CN 107085032A
Authority
CN
China
Prior art keywords
aldehyde
maldi
tof
polypeptide
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201710083984.8A
Other languages
Chinese (zh)
Inventor
唐春雷
冯柏年
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jiangnan University
Original Assignee
Jiangnan University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jiangnan University filed Critical Jiangnan University
Priority to CN201710083984.8A priority Critical patent/CN107085032A/en
Publication of CN107085032A publication Critical patent/CN107085032A/en
Pending legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00Sampling; Preparing specimens for investigation
    • G01N1/28Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848Methods of protein analysis involving mass spectrometry
    • G01N33/6851Methods of protein analysis involving laser desorption ionisation mass spectrometry

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Optics & Photonics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)

Abstract

本发明公开了一种化学衍生化基质辅助激光解析电离‑飞行时间质谱技术(MALDI‑TOF‑MS)的分析方法。本发明首先使用二醛类化合物对含有氨基结构药物代谢物进行修饰,使得药物代谢代谢物能够衍生出带有醛基的基团,再使用多肽对醛基衍生物进行衍生化,通过MALDI‑TOF‑MS检测。将药物代谢产物多肽化后能够得到简洁单一的准分子离子峰,不仅显著改善了这些代谢产物在质谱中的辨识度,也极大的提高了药物代谢物在质谱中检测灵敏度。该方法灵敏度高、应用范围广、操作便捷、基质干扰极小、样品需求量低,无需制备附在的基质和衍生化试剂,即可定量检测代谢物中含量极低的氨基代谢产物。在代谢组学研究中有很大的应用前景。The invention discloses an analysis method of chemical derivatization matrix-assisted laser desorption ionization-time-of-flight mass spectrometry (MALDI-TOF-MS). The present invention first uses dialdehyde compounds to modify drug metabolites containing amino structures, so that drug metabolites can derive groups with aldehyde groups, and then use polypeptides to derivatize the aldehyde derivatives, and then use MALDI‑TOF ‑MS detection. After peptidification of drug metabolites, simple and single quasi-molecular ion peaks can be obtained, which not only significantly improves the identification of these metabolites in mass spectrometry, but also greatly improves the detection sensitivity of drug metabolites in mass spectrometry. The method has high sensitivity, wide application range, convenient operation, minimal matrix interference, and low sample requirement. It can quantitatively detect amino metabolites with extremely low content in metabolites without preparing attached matrix and derivatization reagents. It has great application prospects in metabolomics research.

Description

一种多肽衍生化方法及其在MALDI-TOF-MS检测药物代谢物中 的应用A Peptide Derivatization Method and Its Application in MALDI-TOF-MS Detection of Drug Metabolites Applications

技术领域technical field

本发明涉及质谱检测领域,具体的为利用多肽衍生化代谢产物,结合MALDI-TOF-MS的方法及其在代谢组学领域的应用。The invention relates to the field of mass spectrometry detection, in particular to the method of utilizing polypeptide derivatized metabolites combined with MALDI-TOF-MS and its application in the field of metabolomics.

背景技术Background technique

代谢组学是继基因组学和蛋白组学之后,又一表征生命体系状况的研究领域,生物体内的代谢物的检测对研究基因表达、探索生命过程、诊断疾病和预防疾病等方面都具有深刻意义。因此,对代谢物分析是分析化学领域,乃至生命科学领域中的一个重要方向。Metabolomics is another research field that characterizes the status of living systems after genomics and proteomics. The detection of metabolites in organisms has profound significance for the study of gene expression, exploration of life processes, diagnosis of diseases, and prevention of diseases. . Therefore, the analysis of metabolites is an important direction in the field of analytical chemistry, and even in the field of life sciences.

质谱作为小分子代谢物研究的重要手段,具有灵敏度高、专一性好、定性能力强等显著优点。目前对小分子代谢物最常见的质谱检测技术是液相色谱-质谱联用。虽然LC-ESI-MS的灵敏度高,但是LC-MS的检测时间长,不适用与快速高通量分析。Mass spectrometry, as an important method for the study of small molecule metabolites, has significant advantages such as high sensitivity, good specificity, and strong qualitative ability. Currently, the most common mass spectrometric detection technique for small molecule metabolites is liquid chromatography-mass spectrometry. Although the sensitivity of LC-ESI-MS is high, the detection time of LC-MS is long, which is not suitable for rapid high-throughput analysis.

基质辅助激光解析电离-飞行时间质谱(MALDI-TOF-MS)由于检测快速、简便、高通量等特点,被广泛应用于DNA、蛋白质、多肽、多糖等大分子样品的检测。考虑到MALDI-TOF-MS检测的快速、简便、高灵敏度、高通量等优势,我们尝试将其拓展到对小分子代谢物的检测。MALDI-DOF-MS虽然在检测大分子物质上具有显著的优越性,但不适合检测代谢物这种小分子物质,主要是由于其通常所用的基质CHCA、DHB、3-HPA、2,4,6-THP等在小分子(<500Da)区段会对目标分析物有严重的基质干扰。为克服这一缺点,现有文献报道的方法主要分为两类:1)采用基质干扰小的基质,比如多孔硅、纳米微球、金属氧化物、碳材料等,但依然没有一种方便、广泛适用于基质被开发出来;2)设计大分子衍生化试剂衍生小分子待测物,现有文献报道的衍生化试剂的制备通常很繁琐和一定局限性。因此,在小分子化学物MALDI-TOF-MS分析中迫切需要发展一种简便的、高灵敏度、普适的衍生方法。Matrix-assisted laser desorption ionization-time-of-flight mass spectrometry (MALDI-TOF-MS) is widely used in the detection of macromolecular samples such as DNA, proteins, peptides, and polysaccharides due to its rapid, simple, and high-throughput characteristics. Considering the advantages of MALDI-TOF-MS detection such as rapidity, simplicity, high sensitivity, and high throughput, we tried to extend it to the detection of small molecule metabolites. Although MALDI-DOF-MS has significant advantages in the detection of macromolecular substances, it is not suitable for the detection of small molecular substances such as metabolites, mainly because of the commonly used matrix CHCA, DHB, 3-HPA, 2,4, 6-THP etc. will have serious matrix interference to the target analyte in the small molecule (<500Da) segment. In order to overcome this shortcoming, the methods reported in the existing literature are mainly divided into two categories: 1) the matrix with little matrix interference is adopted, such as porous silicon, nano-microspheres, metal oxides, carbon materials, etc., but there is still no convenient, It is widely applicable to the development of matrices; 2) Design macromolecular derivatization reagents to derivate small molecule analytes. The preparation of derivatization reagents reported in the existing literature is usually very cumbersome and has certain limitations. Therefore, it is urgent to develop a simple, highly sensitive and universal derivatization method in the analysis of small molecule chemicals by MALDI-TOF-MS.

本发明针对上述问题,首次开发以多肽作为衍生化试剂来衍生小分子代谢物的新型MALDI-TOF-MS检测手段,从而克服MALDI-TOF-MA在小分子物质检测方面的优势,开拓MALDI-TOF-MS在代谢组学检测领域的应用。具有操作简便、快速、样品用量少等优点,特别适用于生物样品的分析。Aiming at the above problems, the present invention firstly develops a novel MALDI-TOF-MS detection method using polypeptide as a derivatization reagent to derivatize small molecule metabolites, thereby overcoming the advantages of MALDI-TOF-MA in the detection of small molecule substances and developing MALDI-TOF - Application of MS in the field of metabolomics detection. It has the advantages of simple and fast operation, less sample consumption, etc., and is especially suitable for the analysis of biological samples.

发明内容Contents of the invention

本发明要解决的技术问题在于提供一种能应用于小分子代谢物检测领域中,结合化学衍生化策略的具有高灵敏度和普适性的MALDI-TOF-MS分析方法;The technical problem to be solved by the present invention is to provide a highly sensitive and universal MALDI-TOF-MS analysis method that can be applied in the field of detection of small molecule metabolites and combined with chemical derivatization strategies;

本发明提供的衍生化技术和分析方案包括如下步骤:The derivation technology and analysis scheme provided by the present invention comprise the following steps:

(1)通过PM3方法对多肽进行分子模拟和计算后,筛选到用于衍生化的多肽,该多肽含有在MALDI源中易电离的精氨酸、苯丙氨酸等基团;(1) After molecular simulation and calculation of the polypeptide by the PM3 method, the polypeptide used for derivatization is screened, and the polypeptide contains groups such as arginine and phenylalanine that are easily ionized in the MALDI source;

(2)步骤(1)获得的多肽衍生待测小分子物质,使这些小分子带上易电离的氨基酸残基链。(2) The polypeptide obtained in step (1) is used to derivate small molecular substances to be tested, so that these small molecules are equipped with easily ionized amino acid residue chains.

本发明通过将含有氨基的化合物通过二醛衍生化,再通过分子模拟筛选出高灵敏度的多肽作为衍生化试剂,用N端修饰半胱氨酸和马来酰亚胺的多肽分别衍生醛类化合物类化合物,再用MALDI-TOF-MS检测这些经过多肽标记的小分子代谢物。The present invention derivatizes amino group-containing compounds through dialdehyde, and then screens high-sensitivity polypeptides as derivatization reagents through molecular simulation, and uses N-terminal modified cysteine and maleimide polypeptides to derivate aldehyde compounds respectively. Then use MALDI-TOF-MS to detect these peptide-labeled small molecule metabolites.

一种衍生化方法:采用序列为CFRGLRGF的多肽P2和序列为KFRGLRGF(Lys上修饰马来酰亚胺)的多肽P7分别作为醛类物质的衍生化试剂,水作为反应溶剂,磷酸缓冲溶液作为缓冲剂;A derivatization method: the polypeptide P2 whose sequence is CFRGLRGF and the polypeptide P7 whose sequence is KFRGLRGF (modified maleimide on Lys) are used as derivatization reagents of aldehyde substances, water is used as a reaction solvent, and phosphate buffer solution is used as a buffer agent;

反应条件为:醛类化合物/多肽P2(20-100,c/c)加入到pH5-7的磷酸缓冲溶液中,4-37℃下衍生0.2-2h;The reaction conditions are: aldehyde compound/polypeptide P2 (20-100, c/c) is added to a phosphate buffer solution with a pH of 5-7, and derivatized at 4-37°C for 0.2-2h;

所述的衍生化反应是指含有Cys的多肽与醛类化合物发生的脱水缩合反应。The derivatization reaction refers to the dehydration condensation reaction between the Cys-containing polypeptide and the aldehyde compound.

优选地,醛类化合物、多肽P2以摩尔比为50:1加入到pH为4的磷酸缓冲溶液中,25℃下,发生脱水缩合反应,5h。Preferably, the aldehyde compound and the polypeptide P2 are added to a phosphate buffer solution with a pH of 4 at a molar ratio of 50:1, and a dehydration condensation reaction occurs at 25° C. for 5 hours.

由于所述的多肽衍生化试剂带有容易在MALDI-MS中结合质子发生电离的氨基酸残基,包括Arg(精氨酸),Phe(苯丙氨酸)等,发现筛选出的多肽具有较高的质子亲和势,从而在质谱中容易结合质子,具有高灵敏度。Since the polypeptide derivatization reagent has amino acid residues that are easily ionized in combination with protons in MALDI-MS, including Arg (arginine), Phe (phenylalanine), etc., it is found that the screened polypeptide has a higher proton affinity, so that it is easy to bind protons in mass spectrometry and has high sensitivity.

一种多肽化衍生结合MALDI-TOF-MS的定量分析方法:将小分子待测物衍生化后,与相应的稳定同位素内标1:1混匀,按照1μL待测液混合1μL基质(CHCA)点板;室温吹干后进入基质辅助激光解析电离-飞行时间质谱分析,根据目标分析物谱峰强度与稳定同位素谱峰强度的比值对其进行定量分析。A quantitative analysis method of peptide derivatization combined with MALDI-TOF-MS: After derivatizing the small molecule analyte, mix it with the corresponding stable isotope internal standard 1:1, mix 1 μL matrix (CHCA) with 1 μL test solution Spot the plate; after drying at room temperature, enter the matrix-assisted laser desorption ionization-time-of-flight mass spectrometry analysis, and perform quantitative analysis according to the ratio of the peak intensity of the target analyte spectrum to the peak intensity of the stable isotope spectrum.

所述的多肽化衍生法结合MALDI-TOF-MS的分析方法在代谢组学分析领域中的应用:经筛选用于衍生化的多肽含有在MALDI源中易电离的Arg(精氨酸)、Phe(苯丙氨酸)基团,标记待测小分子物质后可以使这些小分子带入易电离的氨基酸残基链,显著增强它们在MALDI-TOF-MS中的电离化效率,从而导致方法的灵敏度得到极大的提高。由于多肽在MALDI-TOF-MS中的最低检出限(LOD)可以达到fmol,多肽衍生的小分子待测物在质谱中的LOD也可以达到fmol级别。而且,这种多肽化衍生策略可应用许多其他小分子化学物的检测,除了发明中所述的醛类化合物外,还可以拓展到酮类、羧酸类、醇酚类、酯类等小分子化合物的MALDI-TOF-MS分析中,这些小分子化合物的检测对代谢组学的研究意义重大。Application of the described polypeptide derivatization method combined with MALDI-TOF-MS analysis method in the field of metabolomics analysis: the polypeptides screened for derivatization contain Arg (arginine), Phe, which are easily ionized in MALDI sources (Phenylalanine) group, after labeling the small molecules to be tested, these small molecules can be brought into the easily ionized amino acid residue chain, which significantly enhances their ionization efficiency in MALDI-TOF-MS, thus leading to the method’s Sensitivity is greatly improved. Since the minimum detection limit (LOD) of peptides in MALDI-TOF-MS can reach fmol, the LOD of peptide-derived small molecule analytes in mass spectrometry can also reach fmol levels. Moreover, this peptide derivatization strategy can be applied to the detection of many other small molecule chemicals. In addition to the aldehyde compounds described in the invention, it can also be extended to small molecules such as ketones, carboxylic acids, alcohols and phenols, and esters. In the MALDI-TOF-MS analysis of compounds, the detection of these small molecular compounds is of great significance to the research of metabolomics.

本发明的有益效果如下:The beneficial effects of the present invention are as follows:

1.本发明中,方法操作简便,待测物标记后直接用MALDI-TOF-MS分析。1. In the present invention, the method is easy to operate, and the analyte is directly analyzed by MALDI-TOF-MS after labeling.

2.本发明设计的多肽化衍生方法可以显著提高小分子待测物在MALDI-TOF-MS中的检测灵敏度(灵敏度比衍生之前提高了50000倍),检出限可达到fmol级别。2. The peptide derivation method designed in the present invention can significantly improve the detection sensitivity of small molecule analytes in MALDI-TOF-MS (the sensitivity is increased by 50,000 times compared with that before derivation), and the detection limit can reach the fmol level.

3.本发明用到的多肽衍生化试剂使待测小分子带上了分子量很大的标记物,避免了MALDI-TOF-MS中低分子区段(<500Da)基质效应对检测的干扰。3. The polypeptide derivatization reagent used in the present invention makes the small molecule to be tested bear a marker with a large molecular weight, which avoids the interference of the matrix effect of the low molecular segment (<500Da) in MALDI-TOF-MS on the detection.

4.本发明涉及的多肽及同位素多肽都可以购买到商品化的产品,利用定量分析。4. The polypeptides and isotopic polypeptides involved in the present invention can be purchased as commercial products and used for quantitative analysis.

5.本发明设计的衍生化反应具有较高的普适性,由于衍生化试剂多肽上有许多可供修饰的基团,利用多种小分子化合物的分析,具有很高的应用前景。5. The derivatization reaction designed in the present invention has high universality. Since there are many groups available for modification on the polypeptide of the derivatization reagent, the analysis of various small molecular compounds has a high application prospect.

具体实施方式detailed description

1.工作溶液的配置:将衍生化的多肽溶于水中,配置成100μM的溶液备用,阿霉素代谢物的醛类衍生物待测物溶解于水货甲醇中配置成储备液。1. Configuration of the working solution: Dissolve the derivatized polypeptide in water to prepare a 100 μM solution for later use, and dissolve the aldehyde derivative of doxorubicin metabolite to be tested in parallel methanol to prepare a stock solution.

2.醛基化代谢产物的制备,将代谢产物与二醛类化合物,按照摩尔比为1:1.2的比例溶解在醇类溶剂中,加入1滴冰醋酸,50℃下搅拌反应,旋干溶剂备用。2. Preparation of aldehyde metabolites. Dissolve the metabolites and dialdehyde compounds in alcohol solvents at a molar ratio of 1:1.2, add 1 drop of glacial acetic acid, stir the reaction at 50°C, and spin dry the solvent spare.

3.多肽化衍生物方法为:将多肽衍生化试剂盒待测物溶解在水溶液中或其他溶剂,按照适当的配比加入到一定pH的磷酸缓冲液中,使待测物在反应体系中的浓度为10μM,涡旋混合后在适宜的温度下进行衍生化反应。衍生化条件为醛类化合物:多肽P2(20-100,c/c)加入到pH为4-6的磷酸缓冲溶液中,25-37℃下衍生化1-10小时。3. The method of polypeptide derivatization is as follows: dissolve the test substance of the polypeptide derivatization kit in aqueous solution or other solvents, and add it into a certain pH phosphate buffer according to an appropriate proportion, so that the concentration of the test substance in the reaction system The concentration was 10 μM, and the derivatization reaction was carried out at an appropriate temperature after vortex mixing. Derivatization conditions are aldehyde compounds: polypeptide P2 (20-100, c/c) is added to a phosphate buffer solution with a pH of 4-6, and derivatized at 25-37° C. for 1-10 hours.

4.衍生化反应结束后,将产物溶液与稳定同位素内标溶液混合,涡旋混匀后,按照1μL样品混合1μL基质(CHCA)点板;室温风干后进入基质辅助激光解析电离-飞行时间质谱,采用正离子反射模式分析。4. After the derivatization reaction is completed, mix the product solution with the stable isotope internal standard solution, vortex and mix, and mix 1 μL matrix (CHCA) according to 1 μL sample to spot the plate; after air-drying at room temperature, enter matrix-assisted laser desorption ionization-time-of-flight mass spectrometry , analyzed in positive ion reflectance mode.

5.步骤4中所述的稳定同位素内标制备方法为,将稳定同位素多肽P2(多肽亮氨酸上的N和6个C标记),与过量的醛基化合物进行衍生化后,真空旋干,以除去过量小分子,再复溶于水中职称内标液。5. The method for preparing the stable isotope internal standard described in step 4 is to derivatize the stable isotope polypeptide P2 (N and 6 C marks on the polypeptide leucine) with an excess of aldehyde compound, and spin dry in vacuum , to remove excess small molecules, and then redissolve in water title internal standard solution.

6.步骤4中所述的质谱检测条件为:Waters公司的基质辅助解析电离-飞行时间质谱仪(MALDI-TOF-MS)。MALDI-MS分析采用波长为337nm的氮气激光器,其脉冲宽度为3ns,采用20kV的加速电压,在正离子反射模式下进行检测。每张谱图是200次激光扫描的平均结果。6. The mass spectrometry detection condition described in step 4 is: Matrix-Assisted Desorption Ionization-Time-of-Flight Mass Spectrometer (MALDI-TOF-MS) of Waters Company. MALDI-MS analysis uses a nitrogen laser with a wavelength of 337nm, a pulse width of 3ns, an accelerating voltage of 20kV, and detection in positive ion reflection mode. Each spectrum is the average of 200 laser scans.

实施例1 阿霉素经醛基、多肽衍生化后检出限测定Example 1 Determination of detection limit of doxorubicin after derivatization with aldehyde group and polypeptide

取1mmol阿霉素溶解在5mL甲醇中,加入1.1mmol的乙二醛,加入一滴冰醋酸催化反应,50℃下搅拌反应3小时,薄层色谱监控反应进程,反应完全后减压除去溶剂后所得席夫碱备用。将多肽衍生化试剂盒待测物溶解在水溶液中,加入到一定pH的磷酸缓冲液中,使待测物在反应体系中的浓度为10μM,涡旋混合后在适宜的温度下进行衍生化反应。衍生化条件为醛类化合物:多肽P2(20-100,c/c)加入到pH为4-6的磷酸缓冲溶液中,25-37℃下衍生化1-10小时。按照1μL基质点板;室温吹干后进入基质辅助激光解析电离-飞行时间质谱分析,得到阿霉素的检出限。Dissolve 1mmol of doxorubicin in 5mL of methanol, add 1.1mmol of glyoxal, add a drop of glacial acetic acid to catalyze the reaction, stir the reaction at 50°C for 3 hours, monitor the progress of the reaction by thin-layer chromatography, and remove the solvent under reduced pressure after the reaction is complete. Schiff's base spare. Dissolve the test substance of the peptide derivatization kit in an aqueous solution, add it to a certain pH phosphate buffer, make the concentration of the test substance in the reaction system 10μM, vortex and mix and carry out the derivatization reaction at a suitable temperature . Derivatization conditions are aldehyde compounds: polypeptide P2 (20-100, c/c) is added to a phosphate buffer solution with a pH of 4-6, and derivatized at 25-37° C. for 1-10 hours. Spot the plate with 1 μL of matrix; after drying at room temperature, enter matrix-assisted laser desorption ionization-time-of-flight mass spectrometry analysis to obtain the detection limit of doxorubicin.

实施例2 MCF-7细胞中阿霉素代谢产物含量的测定The determination of the content of metabolites of doxorubicin in embodiment 2 MCF-7 cells

将事先加药的MCF-7细胞破碎后,提取阿霉素代谢物,取1μL阿霉素代谢物提取物溶解在5mL甲醇中,加入1.1μL的丙二醛,加入一滴冰醋酸催化反应,50℃下搅拌反应3小时,薄层色谱监控反应进程,反应完全后减压除去溶剂后所得席夫碱备用。将多肽衍生化试剂盒待测物溶解在水溶液中,加入到一定pH的磷酸缓冲液中,使待测物在反应体系中的浓度为10μM,涡旋混合后在适宜的温度下进行衍生化反应。衍生化条件为醛类化合物:多肽P2(20-100,c/c)加入到pH为4-6的磷酸缓冲溶液中,25-37℃下衍生化1-10小时。加入稳定同位素内标,使其浓度为1μM,混匀后取1μL基质(CHCA)点板,室温风干后进入基质辅助激光解析电离飞行时间质谱,采用正离子反射模式分析,根据目标分析物的谱线强度与稳定同位素谱线强队的比值进行定量分析,最终测得加药3h的MCF-7细胞中阿霉素醇的含量为2.3μM。After the pre-dosed MCF-7 cells were crushed, doxorubicin metabolites were extracted, 1 μL of doxorubicin metabolite extract was dissolved in 5 mL of methanol, 1.1 μL of malondialdehyde was added, and a drop of glacial acetic acid was added to catalyze the reaction, 50 The reaction was stirred at ℃ for 3 hours, and the progress of the reaction was monitored by thin-layer chromatography. After the reaction was complete, the solvent was removed under reduced pressure to obtain the Schiff base for future use. Dissolve the test substance of the peptide derivatization kit in an aqueous solution, add it to a certain pH phosphate buffer, make the concentration of the test substance in the reaction system 10μM, vortex and mix and carry out the derivatization reaction at a suitable temperature . Derivatization conditions are aldehyde compounds: polypeptide P2 (20-100, c/c) is added to a phosphate buffer solution with a pH of 4-6, and derivatized at 25-37° C. for 1-10 hours. Stable isotope internal standard was added to make the concentration 1 μM. After mixing, 1 μL of matrix (CHCA) was taken to spot the plate. After air-drying at room temperature, it was put into matrix-assisted laser desorption ionization time-of-flight mass spectrometry, and positive ion reflectance mode was used for analysis. According to the target analyte’s spectrum The ratio of line intensity to stable isotope spectrum line intensity was quantitatively analyzed, and finally the content of doxorubicinol in MCF-7 cells added for 3 hours was 2.3 μM.

Claims (5)

1. a kind of polypeptide derives with the method for changing amino metabolism structure micromolecular compound combination MALDI-TOF-MS, its feature Comprise the following steps:
(1) micromolecular compound:Using twain-aldehyde compound compound as linking arm, modified to amino-compound, made by condensation reaction Drug metabolite structure derives aldehyde groups.
(2) many derived chemotactic peptide micromolecular compounds:By aldehyde compound, polypeptide with mol ratio 50-100:1 is added to pH for 4-6 Phosphate buffer in, condensation reaction occurs at 5-37 DEG C, the amino acid sequence N-terminal cysteine modified of polypeptide is used as aldehyde Class compound derivatization reagent.
(3) MALDI-TOF-MS is analyzed:Analyte derivative is according to 1 μ L sample mixed-matrix alpha-cyano -4- hydroxycinnamic acids CHCA Point plate, room temperature carries out Matrix Assisted Laser Desorption lonization-Time of Flight after air-drying, using cation reflective-mode.
2. aldehyde radical derivatization method according to claim 1 is characterized in that, twain-aldehyde compound chemical combination is selected from glyoxal, the third two Aldehyde, butanedial, glutaraldehyde, hexandial, dialdehyde in heptan, suberic aldehyde.The reaction dissolvent of twain-aldehyde compound compound and metabolite is selected from first Alcohol, ethanol, isopropanol, n-butanol, the tert-butyl alcohol, the reaction time are 0.5-5h, and reaction temperature is 20-100 DEG C.
3. polypeptide derivatization method according to claim 1, it is characterised in that aldehyde derivative in step (1) with it is many The mol ratio of peptide is 50-100:1 is added in the phosphate buffer that pH is 4-6, occurs condensation reaction, the reaction time is 0.5- 5h。
4. a kind of polypeptide derives with the analysis method for changing amino metabolism structure micromolecular compound combination MALDI-TOF-MS, its It is characterised by, after small molecule determinand is combined according to 1-3 method aldehyde radical derivative and polypeptide, according to 1 μ L sample mixed-matrixes Alpha-cyano -4- hydroxycinnamic acids CHCA point plates, room temperature carries out Matrix Assisted Laser Desorption lonization-Time of Flight after air-drying and determined Property analysis.Can directly can be with corresponding stable isotope 1:1 mixes, according to 1 μ L sample mixed-matrix alpha-cyano -4- hydroxyl meat Cinnamic acid CHCA point plates, room temperature carries out Matrix Assisted Laser Desorption lonization-Time of Flight analysis after air-drying, according to target analysis The ratio of material spectral strength and stable isotope spectral strength carries out quantitative analysis to it.
5. the application in method described in any one of claim 1-3 metabonomic analysis field again.
CN201710083984.8A 2017-02-16 2017-02-16 A Peptide Derivatization Method and Its Application in MALDI‑TOF‑MS Detection of Drug Metabolites Pending CN107085032A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710083984.8A CN107085032A (en) 2017-02-16 2017-02-16 A Peptide Derivatization Method and Its Application in MALDI‑TOF‑MS Detection of Drug Metabolites

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710083984.8A CN107085032A (en) 2017-02-16 2017-02-16 A Peptide Derivatization Method and Its Application in MALDI‑TOF‑MS Detection of Drug Metabolites

Publications (1)

Publication Number Publication Date
CN107085032A true CN107085032A (en) 2017-08-22

Family

ID=59615258

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710083984.8A Pending CN107085032A (en) 2017-02-16 2017-02-16 A Peptide Derivatization Method and Its Application in MALDI‑TOF‑MS Detection of Drug Metabolites

Country Status (1)

Country Link
CN (1) CN107085032A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114047269A (en) * 2022-01-13 2022-02-15 浙江湃肽生物有限公司南京分公司 Detection method of acetyl hexapeptide-8
CN114166976A (en) * 2021-12-08 2022-03-11 桂林医学院 A method of adjuvant tracer analysis of drug content in health products
CN114660164A (en) * 2022-01-11 2022-06-24 生物岛实验室 MALDI detection method of catechol and derivatives thereof
CN115201385A (en) * 2022-06-22 2022-10-18 河北医科大学 A kind of derivatization reagent for electrospray mass spectrometry detection which makes amino small molecule carry two charges and its preparation method and application

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114166976A (en) * 2021-12-08 2022-03-11 桂林医学院 A method of adjuvant tracer analysis of drug content in health products
CN114166976B (en) * 2021-12-08 2024-02-27 桂林医学院 Method for analyzing drug content in health care product by tracing auxiliary agent
CN114660164A (en) * 2022-01-11 2022-06-24 生物岛实验室 MALDI detection method of catechol and derivatives thereof
CN114047269A (en) * 2022-01-13 2022-02-15 浙江湃肽生物有限公司南京分公司 Detection method of acetyl hexapeptide-8
CN114047269B (en) * 2022-01-13 2022-04-15 浙江湃肽生物有限公司南京分公司 Detection method of acetyl hexapeptide-8
CN115201385A (en) * 2022-06-22 2022-10-18 河北医科大学 A kind of derivatization reagent for electrospray mass spectrometry detection which makes amino small molecule carry two charges and its preparation method and application
CN115201385B (en) * 2022-06-22 2024-01-09 河北医科大学 Derivatization reagent for electrospray mass spectrometry detection for enabling amino small molecules to carry two charges, and preparation method and application thereof

Similar Documents

Publication Publication Date Title
CN105699476B (en) A kind of polypeptide deriving method and its application in MALDI TOF MS detect micromolecular compound
Chen Review of a current role of mass spectrometry for proteome research
US8633031B2 (en) Expression quantification using mass spectrometry
CN112225782B (en) Specific peptides and methods for determining the content of structural proteins in COVID-19 vaccines
JP2010500579A (en) Method for analyzing compounds containing thyroxine
EP2126584A1 (en) Direct mass spectrometric analysis of drug candidates targeting protein complexes
Park et al. A simple method for quantification of peptides and proteins by matrix-assisted laser desorption ionization mass spectrometry
Nishikaze Sensitive and structure-informative N-glycosylation analysis by MALDI-MS; ionization, fragmentation, and derivatization
CN107085032A (en) A Peptide Derivatization Method and Its Application in MALDI‑TOF‑MS Detection of Drug Metabolites
JP4328625B2 (en) Labeling reagents and their use
Lee Pharmaceutical applications of liquid chromatography coupled with mass spectrometry (LC/MS)
CN108088945B (en) Absolute quantification method based on dimethylation multiple markers and characteristic fragment ions
CN112326852B (en) Application of a kind of 1-pyrene formaldehyde and detection method of biological small molecule
CN108424436B (en) Application of MALDI-TOF mass spectrometry probe in preparation of gamma-glutamyl transpeptidase detection kit
Dave et al. Preparation and analysis of proteins and peptides using MALDI TOF/TOF mass spectrometry
Chen et al. Coupling matrix-assisted ionization with high resolution mass spectrometry and electron transfer dissociation to characterize intact proteins and post-translational modifications
CN101274909B (en) Brominated1-[3-(4-maleimido phenoxyl)propyl] trimethylamin, preparation and application thereof
CN106198710A (en) A kind of MALDI TOF MS detection method of micromolecular compound and fullerene label are as the application of mass-to-charge ratio shift reagen
Sandoval Matrix‐assisted laser desorption/ionization time‐of‐flight mass analysis of peptides
Zhai et al. RABA (reductive alkylation by acetone): A novel stable isotope labeling approach for quantitative proteomics
Liao et al. α-Cyano-3-aminocinnamic acid: A novel reactive matrix for qualitative and quantitative analysis of plant N-glycans by MALDI-MS
CN101210928B (en) Method for analyzing carbohydrate-binding protein by functional sugar chip and flight mass spectrometer
CN110903444B (en) Polymer silver-coated micro-nano particle and method for detecting urine micromolecules by using same
CN102175752A (en) Perfluoro acid substance high-sensitivity detecting method assisted by organic proton alkali matrix
CN117092199B (en) Method for time-of-flight mass spectrometry detection using tungsten carbide nanomaterial matrix

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20170822

WD01 Invention patent application deemed withdrawn after publication